Graves' disease
RecruitingLong-Term Study of Imeroprubart in Adults With Graves' Disease
- Disease:Graves' disease
- Substances:IMEROPRUBART
Italy- Participants:18–64 years · 65+ years
- Substances:IMEROPRUBART
- Sponsor:Immunovant Sciences GmbH
Rare diseases
Investigational molecules
Locations
Back to Italy676 clinical trials in Turin, Italy across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple myeloma, colorectal cancer, and breast cancer treatments. Studies include evaluation of targeted therapies and immunotherapy approaches for various stages of disease.
Several trials are investigating combination therapies and maintenance treatments to improve patient outcomes.
Research centered on improving outcomes in kidney transplantation, with particular focus on preventing delayed graft function and optimizing post-transplant care.
Studies aim to enhance transplant success rates and reduce complications in organ recipients.
Investigations into treatments for various autoimmune disorders, including Crohn's Disease and pyoderma gangrenosum. Studies evaluate new biological therapies and combination treatments.
Focus on developing targeted treatments to improve disease control and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.